India, July 21 -- Today's top biotech gainers include Wellgistics following its rebranding, Femasys, which recently resolved its Nasdaq compliance issue, Vor Bio with continued progress in its Telitacicept program, and Sol-Gel Technologies as investors look ahead to key SGT-610 Phase 3 data, among others.
Read on.
WGRX Rebranded
Wellgistics Health Inc. (WGRX) was one of the top gainers on Tuesday, as the company announced the completion of its name change to DataMEDS AI, Inc. The company will begin trading under the stock symbol 'MEDS' on the NASDAQ Capital Market stock exchange on Wednesday, July 22, 2026.
The name change was made to reflect an updated healthcare ecosystem aligned with AI integration to optimise patients' control over ...